| . | Group 1 (orb) . | Group 2 (control) . | P value . |
|---|---|---|---|
| Male sex | 15 (71.4) | 14 (66.7) | 0.739 |
| Age | 58 (21) | 63 (14) | 0.358 |
| Paroxysmal AF | 18 (85.7) | 20 (95.2) | 0.606 |
| Structural heart disease | 2 (9.5) | 4 (19.0) | 0.663 |
| CHADS2 score >1 | 8 (38.1) | 5 (23.8) | 0.317 |
| BMI | 25.9 (11.4) | 27.8 (7.3) | 0.920 |
| . | Group 1 (orb) . | Group 2 (control) . | P value . |
|---|---|---|---|
| Male sex | 15 (71.4) | 14 (66.7) | 0.739 |
| Age | 58 (21) | 63 (14) | 0.358 |
| Paroxysmal AF | 18 (85.7) | 20 (95.2) | 0.606 |
| Structural heart disease | 2 (9.5) | 4 (19.0) | 0.663 |
| CHADS2 score >1 | 8 (38.1) | 5 (23.8) | 0.317 |
| BMI | 25.9 (11.4) | 27.8 (7.3) | 0.920 |
Dichotomous variables are presented as n (%) and continuous variables as median (interquartile range).
AF, atrial fibrillation; BMI, body mass index.
| . | Group 1 (orb) . | Group 2 (control) . | P value . |
|---|---|---|---|
| Male sex | 15 (71.4) | 14 (66.7) | 0.739 |
| Age | 58 (21) | 63 (14) | 0.358 |
| Paroxysmal AF | 18 (85.7) | 20 (95.2) | 0.606 |
| Structural heart disease | 2 (9.5) | 4 (19.0) | 0.663 |
| CHADS2 score >1 | 8 (38.1) | 5 (23.8) | 0.317 |
| BMI | 25.9 (11.4) | 27.8 (7.3) | 0.920 |
| . | Group 1 (orb) . | Group 2 (control) . | P value . |
|---|---|---|---|
| Male sex | 15 (71.4) | 14 (66.7) | 0.739 |
| Age | 58 (21) | 63 (14) | 0.358 |
| Paroxysmal AF | 18 (85.7) | 20 (95.2) | 0.606 |
| Structural heart disease | 2 (9.5) | 4 (19.0) | 0.663 |
| CHADS2 score >1 | 8 (38.1) | 5 (23.8) | 0.317 |
| BMI | 25.9 (11.4) | 27.8 (7.3) | 0.920 |
Dichotomous variables are presented as n (%) and continuous variables as median (interquartile range).
AF, atrial fibrillation; BMI, body mass index.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
